A quest to end breast cancer slows as the Trump-Harvard dispute drags on
A new study found that more than half of drugs approved by the FDA since 2000 used NIH-fun
A new study found that more than half of drugs approved by the FDA since 2000 used NIH-fun
"Careful risk management enables investments with significant results," said professor Andrew W.
Michael Siegel, director of Cybersecurity at MIT Sloan (CAMS), believes cyberattacks are bec
All the LLMs — which are infamously sycophantic — tweaked their answers when questions hinted at a user's demographics or political affiliation.
The growth of quantum technology globally requires urgent and proactive approach to cybersecurity, given the risk and magnitude of threats posed.
Many economists believe claims by CEOs and the tech industry are — at least on an economy-wide level — overblown.
A study by senior lecturer Robert Pozen and co-authors found that in Britain, the shift t
In June 2025, Health and Human Services Secretary Robert F. Kennedy Jr.
Professor Yasheng Huang says that academic institutions should "claim a larger share of the val
Dina Sherif, executive director of the MIT Kuo Sharper Center for Prosperity and Entrepreneurship